Section 32

What Section 32 does

Section 32 is a venture capital firm founded in 2017 that takes a high-conviction, concentrated investment approach in technology, healthcare, and life sciences companies. The firm organizes its investment activity around five explicit focus areas: Artificial Intelligence, Computational Biology, Physical AI Infrastructure, Cybersecurity, and Enterprise. Its team has backed more than 500 companies and generated more than 150 exits, with cumulative realized value described in the tens of billions of dollars. The firm positions itself as an operating partner rather than a passive capital provider, with stated hands-on support that includes helping portfolio companies hire world-class leadership.

The portfolio spans category-defining companies across multiple cycles and stages, including AI infrastructure and foundational model providers (Scale AI, Cohere, Black Forest Labs, Databricks, Phaidra, Endor Labs, Ema, Humans & AI, Legora), enterprise software and consumer platforms (Slack, CrowdStrike, Gusto, Deel, Coinbase, Uber, 8090), and frontier science and deep technology bets (Neuralink, Physical Intelligence, Infleqtion, SandboxAQ, Basecamp Research, Inceptive, New Limit, Ohalo, Raya, Nest). The breadth of named holdings indicates the firm concentrates capital in a relatively small number of high-conviction positions per fund rather than spreading checks broadly.

Section 32's revenue mechanics follow the standard venture model: management fees on committed capital plus carried interest on fund returns. As a high-conviction fund, the firm concentrates ownership in fewer bets with deeper operational engagement, and uses proceeds, network, and operating support to drive portfolio outcomes rather than relying on portfolio construction alone.

Name

Section 32

Website

https://section32.com

Company type

Private

Founded year

2017

Operating status

Operating

Short description

Section 32 is a venture capital firm founded in 2017 that makes high-conviction, concentrated investments across AI, computational biology, physical AI infrastructure, cybersecurity, and enterprise, partnering with founders on operating support and leadership hiring.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

All Other Financial Investment Activities (52399), Other Financial Investment Activities (5239)

SIC

Investors, Nec (6799)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Venture capital investing
• Early stage funding
• Technology investments
• Portfolio management
• Startup financing

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Revenue model

1. Management Fees: VC firms typically charge management fees on committed capital under management to cover operational expenses.
2. Carried Interest: Performance-based carried interest from successful portfolio company exits, representing the primary economic upside for the fund manager.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Section 32 is a high-conviction venture capital firm that deploys equity capital into transformative technology, healthcare, and life sciences companies from seed through growth stages. In addition to capital, the firm provides hands-on operational support, including recruiting world-class leaders across engineering, AI, and go-to-market functions. The firm operates with deliberate capital constraints to concentrate meaningful time, capital, and attention on a small number of core portfolio relationships.

Product overview

Section 32 is a high-conviction venture capital firm, not a product company. It operates as an investment firm that provides capital, strategic guidance, and talent support to early-stage technology companies. The firm focuses on five core investment areas: Artificial Intelligence, Computational Biology, Physical AI Infrastructure, Cybersecurity, and Enterprise. Section 32 does not offer software products or services but rather invests in and supports portfolio companies, offering hands-on assistance with hiring world-class leaders across engineering, AI, and go-to-market functions. The firm maintains a concentrated portfolio approach, deliberately limiting the number of investments to ensure meaningful time, capital, and attention for each company.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 500+ companies backed across team careers
• +2 more outcomes

Named customers26 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Greylock Partners: Greylock is an enterprise and consumer tech VC with a long track record backing iconic companies. It competes with S32 in enterprise AI and seed-stage rounds, though at substantially larger fund scale.
• Andreessen Horowitz (a16z): a16z is a broad, multi-stage tech VC with significant exposure to AI, bio, and enterprise. It is a comparable investor category but operates at much larger fund scale and competes with S32 for top-tier AI and frontier-tech rounds.
• NEA (New Enterprise Associates): NEA is a broad tech and healthcare VC investing across stages, including AI and biotech. It overlaps with S32 across enterprise and computational biology themes and is a relevant incumbent peer.
• Sequoia Capital: Sequoia is one of the most established tech VCs, investing across AI, enterprise, biotech, and frontier categories. It competes with S32 at the high end of seed and growth deals and represents the incumbent benchmark for AI-era investing.
• General Catalyst: General Catalyst is a multi-stage VC with strong AI, enterprise, and healthcare exposure. It is a broader incumbent that competes with S32 across several of S32's core investment themes.

Direct peers

• Lux Capital: Lux Capital is a venture firm investing in frontier science and technology companies, including AI, robotics, biotech, and quantum. It shares S32's thematic focus on transformative, science-driven companies and concentrated portfolio approach.
• DCVC (Data Collective): DCVC invests in deep-tech and AI-driven companies applying computational approaches to science and industry. It mirrors S32's focus on AI infrastructure, computational biology, and technically differentiated founders.
• Founders Fund: Founders Fund is a high-conviction venture firm that invests in transformative technologies across a small number of concentrated bets. Its 'concentrated, contrarian' philosophy is closely aligned with S32's deliberate few-bet model.
• Innovation Endeavors: Innovation Endeavors is an operator-led venture firm backing deep-tech and AI companies with hands-on support. Its model of operator-driven investing and frontier-tech focus is highly comparable to S32's approach.
• Khosla Ventures: Khosla Ventures is a high-conviction technology VC investing across AI, biotech, sustainability, and enterprise. It directly parallels S32's broad tech/healthcare frontier investing strategy and willingness to back bold technical founders.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/section32vc
• LinkedInlinkedin.com/company/section-32

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Section 32